MannKind | 净收入



Net Income 更改 日
Adma Biologics USD 111.9M 75.99M 2024-12
Dynavax Technologies USD 7.05M 10.54M 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Halozyme Therapeutics USD 137.01M 1000 2024-12
Insmed USD -235548000 15.02M 2024-12
MacroGenics USD -15421000 71.73M 2024-12
MannKind USD 7.42M 4.13M 2024-12
Merck USD 3.74B 586M 2024-12
Novo Nordisk DKK 27.3B 7.25B 2024-09
Pfizer USD 410M 4.06B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Xencor USD -53479000 8.34M 2024-12



MannKind 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.